White label ELPA - ClinicalTrials.eu

Study of loncastuximab tesirine and epcoritamab combination treatment for patients with relapsed or refractory diffuse large B-cell lymphoma

Recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
- Loncastuximab Tesirine
- Epcoritamab
Study comparing tadalafil with ambrisentan versus tadalafil alone in newly diagnosed patients with pulmonary arterial hypertension who have cardiovascular conditions

Recruiting

3 1 1
Investigated Diseases:
- Pulmonary arterial hypertension
Investigated Drugs:
- Ambrisentan
- Tadalafil
Study of drug combination therapy after surgery in patients with resectable pancreatic ductal adenocarcinoma using lab-grown mini-tumors to guide treatment selection

Recruiting

2 1 1 1
Investigated Diseases:
- Adenocarcinoma pancreas
Investigated Drugs:
Study of Tarlatamab and Temozolomide combination treatment in adolescents and adults with high grade brain tumors

Recruiting

1 1 1 1
Investigated Diseases:
- Brain neoplasm
Investigated Drugs:
- Tarlatamab
- Temozolomide
Study of encorafenib and cetuximab treatment for patients with BRAF V600E-mutant metastatic colorectal cancer who previously responded to BRAF inhibitor therapy

Recruiting

2 1 1 1
Investigated Diseases:
- Colorectal cancer metastatic
Investigated Drugs:
- Encorafenib
Study of pembrolizumab and lenvatinib treatment for patients with vulvar cancer

Recruiting

2 1 1 1
Investigated Drugs:
- Lenvatinib
- Pembrolizumab
Study comparing remibrutinib and ocrelizumab in patients with relapsing multiple sclerosis who switch from ocrelizumab treatment

Recruiting

3 1 1 1
Investigated Diseases:
- Relapsing multiple sclerosis
Investigated Drugs:
- Ocrelizumab
- Remibrutinib
+4
Long-term safety study of subcutaneous vedolizumab in children and adolescents with ulcerative colitis or Crohn’s disease

Recruiting

3 1 1 1
Investigated Diseases:
- Colitis ulcerative
- Crohn’s disease
Investigated Drugs:
- Vedolizumab
+4
Study of Obinutuzumab treatment for patients with non-infectious cryoglobulinemia vasculitis who did not respond to or cannot tolerate Rituximab

Recruiting

2 1 1 1
Investigated Diseases:
- Cryoglobulinaemia
Investigated Drugs:
- Obinutuzumab
Study of 177Lu-FAP-2286 alone and with drug combinations for patients with advanced solid tumors including non-small cell lung cancer, breast cancer, and pancreatic cancer

Recruiting

2 1 1 1
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies